Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220025/S008

LimFlow System

LimFlow, Inc. · Decision date Jan 7, 2026

FDA DECISIONP220025/S008

What did the FDA decide?

FDA records P220025/S008 as a supplement to PMA P220025, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 7, 2026.

FDA approval order statement

a manufacturing process change for the soft tip bond
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jan 7, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P220025/S008
Regulatory pathway
PMA supplement
Applicant
LimFlow, Inc.
Product code
QWN
Decision code
OK30
Decision date
Jan 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent graft, infrapopliteal, venous arterialization.

Applicant
LimFlow, Inc.
Product code
QWN
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P220025/S008 received

    Application receipt date recorded by FDA.

  2. P220025/S008 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P220025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220025

Product / regulatory recordCompanyPathwayDecision dateSource
LimFlow SystemP220025/S007
LimFlow, Inc.PMA supplementOct 22, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

LimFlow, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3031 Tisch Way - 110 Plz. W., San Jose, CA, 95128

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records